Abstract
49O Clinical experience of tabelecleucel in Epistein-Barr virus-positive post-transplant lymphoproliferative disease (EBV+ PTLD) involving the central nervous system
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
